Source: International Congress 2017 – Animal models of asthma and allergies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Ravanetti (Amsterdam, Netherlands). Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses. 1138

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Late Breaking Abstract - GATA-3 in lung CD4+T cells drives Interleukin-10 deficiency-induced lung inflammation in asthma Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men Year: 2020 IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Interleukin-33 and Th2 cytokines correlate in acute asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Late Breaking Abstract: A role for IL-25 as ‘initiator‘ in Th2 driven inflammation is restricted to IL-5 high Th2 patients Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Evidence for differential roles of Th1 and Th17 cytokines in the pathogenesis of COPD Source: Annual Congress 2010 - Pathology and immunology of COPD Year: 2010 Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization Source: International Congress 2018 – Molecular and cellular determinants of the developing lung Year: 2018 LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Interferon-γ-pretreated dendritic cells induced dual Th1 and Th2 responses and failed to prevent development of allergic airway inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006 Late Breaking Abstract - Anti-IL-4 and anti-IL-13 dual vaccination using Kinoid technology prevents development of allergic asthma in mice Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 4-1BBL/4-1BB costimulation alleviates airway inflammation by restoring Treg/Th17 balance in allergic asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012